descriptive claim
The interviewer says Anthropic's and OpenAI's biopharma initiatives currently focus heavily on molecule design.
RJ Hanaki · Controlling Biology - Fabian Theis, Helmholtz Munich · 6 Nov 2026
In their words
The transcript segments this claim was taken from
“There's a ton of interest right now in structural biology. Anthropic and OpenAI biopharma initiatives focus heavily on designing molecules right now.”2:13Report a misattribution
0.90how strongly it was put, not whether it is true
0.70importance to the conversation
0.96confidence the claim was read correctly